11.13.14
French orthopedic implant company Implanet has named Brian Kwon M.D. as medical advisor for the United States.
An orthopedic surgeon specializing in the surgical management of adult spine disorders at New England Baptist Hospital in Boston, Mass., Kwon holds a teaching appointment at Tufts University School of Medicine as Assistant Clinical Professor of Orthopedic Surgery. He serves on the editorial board for the Journal of Spinal Disorders & Techniques, a peer-reviewed multidisciplinary journal for spine clinicians. Kwon will assist Implanet in its approach to the adult degenerative spine market in the United States and in the use of its Jazz technology platform.
“The Jazz implant developed by Implanet is a major innovation in the treatment of patients with degenerative spine disorders. Its technical properties give it substantial clinical value, notably in caring for my patients,” said Kwon. “I am pleased to have the opportunity to assist the company with its development efforts and am delighted to provide my experience in order to accelerate the adoption of this technology in the United States.”
According to Alain Meunier, Ph.D., Implanet’s clinical and scientific affairs director, this appointment “goes hand in hand” with recent positive two-year clinical results for Jazz. The in-vitro biomechanical study was conducted in the Orthopedic Biomechanics Laboratory at the Mayo Clini, and showed Jazz’s efficiency in protecting pedicle screws implanted in osteoporotic vertebrae.
An orthopedic surgeon specializing in the surgical management of adult spine disorders at New England Baptist Hospital in Boston, Mass., Kwon holds a teaching appointment at Tufts University School of Medicine as Assistant Clinical Professor of Orthopedic Surgery. He serves on the editorial board for the Journal of Spinal Disorders & Techniques, a peer-reviewed multidisciplinary journal for spine clinicians. Kwon will assist Implanet in its approach to the adult degenerative spine market in the United States and in the use of its Jazz technology platform.
“The Jazz implant developed by Implanet is a major innovation in the treatment of patients with degenerative spine disorders. Its technical properties give it substantial clinical value, notably in caring for my patients,” said Kwon. “I am pleased to have the opportunity to assist the company with its development efforts and am delighted to provide my experience in order to accelerate the adoption of this technology in the United States.”
According to Alain Meunier, Ph.D., Implanet’s clinical and scientific affairs director, this appointment “goes hand in hand” with recent positive two-year clinical results for Jazz. The in-vitro biomechanical study was conducted in the Orthopedic Biomechanics Laboratory at the Mayo Clini, and showed Jazz’s efficiency in protecting pedicle screws implanted in osteoporotic vertebrae.